Cheryl Gault's most recent trade in Rapport Therapeutics Inc. was a trade of 13,987 Common Stock done . Disclosure was reported to the exchange on March 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rapport Therapeutics Inc. | Cheryl Gault | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 13,987 | 171,928 | - | 0 | Common Stock | |
Rapport Therapeutics Inc. | Cheryl Gault | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 129,000 | 129,000 | - | - | Stock Option (Right to Buy) | |
Rapport Therapeutics Inc. | Cheryl Gault | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 88,442 | 88,442 | - | - | Stock Option (Right to Buy) | |
Cyclerion Therapeutics Inc | Cheryl Gault | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) |